These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 19616491

  • 1. Targeting anti-tumor DNA vaccines to dendritic cells via a short CD11c promoter sequence.
    Ni J, Nolte B, Arnold A, Fournier P, Schirrmacher V.
    Vaccine; 2009 Sep 04; 27(40):5480-7. PubMed ID: 19616491
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. 'Survival gene' Bcl-xl potentiates DNA-raised antitumor immunity.
    Kim JH, Chen J, Majumder N, Lin H, Falo LD, You Z.
    Gene Ther; 2005 Oct 04; 12(20):1517-25. PubMed ID: 16052205
    [Abstract] [Full Text] [Related]

  • 6. HPV16E7 tumor antigen modified by KDEL sequence induce specific cytotoxic T lymphocytes-dependent antitumor immunity.
    Yin R, Zheng W, Hao F, Yang XC, Zhong BY, Li QJ.
    J Dermatol Sci; 2009 Aug 04; 55(2):116-22. PubMed ID: 19500947
    [Abstract] [Full Text] [Related]

  • 7. Transcriptional targeting of dendritic cells for gene therapy using the promoter of the cytoskeletal protein fascin.
    Ross R, Sudowe S, Beisner J, Ross XL, Ludwig-Portugall I, Steitz J, Tüting T, Knop J, Reske-Kunz AB.
    Gene Ther; 2003 Jun 04; 10(12):1035-40. PubMed ID: 12776161
    [Abstract] [Full Text] [Related]

  • 8. Prophylactic and therapeutic intervention in IgE responses by biolistic DNA vaccination primarily targeting dendritic cells.
    Sudowe S, Ludwig-Portugall I, Montermann E, Ross R, Reske-Kunz AB.
    J Allergy Clin Immunol; 2006 Jan 04; 117(1):196-203. PubMed ID: 16387606
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Native anti-tumor responses elicited by immunization with a low dose of unmodified live tumor cells.
    Wu S, Wang SQ, Zhang J, Tan XY, Liu JN.
    Int J Oncol; 2006 Mar 04; 28(3):731-6. PubMed ID: 16465379
    [Abstract] [Full Text] [Related]

  • 11. Dendritic cells incubated with irradiated tumor cells effectively stimulate T lymphocyte activation and induce enhanced expression of CD69, CD25 as well as production of IFNgamma and IL4.
    Stegel V, Kopitar A, Jezersek Novaković B, Ihan A, Novaković S.
    Int Immunopharmacol; 2006 Jan 04; 6(1):79-89. PubMed ID: 16332516
    [Abstract] [Full Text] [Related]

  • 12. Truncated TERT mRNA transfected dendritic cells evoke TERT specific antitumor response in vivo.
    Qiu J, Lil GW, Sui YF, Sun YJ, Huang YY, Si SY, Ge W, Song HP.
    Hepatogastroenterology; 2007 Jan 04; 54(75):681-7. PubMed ID: 17591041
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration.
    Hattori Y, Kawakami S, Lu Y, Nakamura K, Yamashita F, Hashida M.
    J Gene Med; 2006 Jul 04; 8(7):824-34. PubMed ID: 16625665
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
    Kim S, Lee JB, Lee GK, Chang J.
    Prostate; 2009 Jun 15; 69(9):938-48. PubMed ID: 19267351
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.